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Abstract
Aim: Little is known about inpatient probiotic and prebiotic consumption or beliefs,
despite their increase in availability. Therefore, the purpose of this research was
to assess inpatient knowledge, use and perceptions of probiotics and prebiotics.
Methods: All subjects were inpatients at two urban medical centers on general
medical/surgical floors. Patients were randomly selected to complete a verbally
administered questionnaire inquiring about probiotic and prebiotic knowledge,
use and perceptions. Patient responses were recorded directly into Survey Monkey (Palo Alto, CA, USA) on a computer.
Results: Patients (n = 200) were 58% were women and 56% were Caucasian with a
mean age of 56 years. More patients were familiar with the term “probiotic” (43%)
compared with “prebiotic” (11%); however, only 20% and 7% could correctly define
probiotics and prebiotics, respectively, from a list of responses. More patients were
consuming probiotics (53%) than prebiotics (38%). The most common probiotic
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and prebiotic products consumed were yogurts (72%) and cereals/granola bars
(55%), respectively. Patients believed probiotics and prebiotics most beneficial for
“digestion or gut health”, but the most common reason to consume these products was “to taste or try” (36% and 43%, respectively). Overall, patients believed
probiotics and prebiotics to be safe; however, they also believed that health claims
could only somewhat be trusted.
Conclusions: This research found that many patients are consuming probiotic and
prebiotic products despite limited awareness of the true meaning of these terms.
As probiotic and prebiotic use is more common, it is important that clinicians are
aware of increased use and provide patients with recommendations based on recent research.
Keywords: clinical nutrition and dietetics, clinical trials, consumers, dietary intake,
food preferences, health beliefs

Introduction
The human gastrointestinal tract is home to trillions of bacteria that have a
symbiotic relationship with the host. These bacteria have many important
functions including immunity, harvesting energy and altering lipid metabolism. Recognition of these important functions has resulted in development
of commercial products that include probiotics and prebiotics. These products are intended to modify gut bacteria to benefit host health.1
A probiotic is a live microorganism that, when administered in adequate
amounts, confers a health benefit on the host.2 Probiotics have been recognized as helpful for health for over 100 years; Élie Metchnikoff received the
Nobel Prize in Medicine in 1908 for his work with gut microbiota and immune system. Yakult (Yakult Honsha Co., Ltd) is a Japanese dairy probiotic
product on the market since 1935. Despite being in existence and recognized for health promotion for over 100 years, probiotics have only recently
become popular, with commercially available probiotics such as Yakult and
Activia (Dannon). The global market for probiotic products is estimated to
be 26 million in 2012 and the market increased by approximately $1.5 billion in a 5-year period.3 A prebiotic is a selectively fermented ingredient that
allows specific changes, both in the composition and/or activity in the gastrointestinal microflora that confer benefits upon host wellbeing and health.4
These prebiotic fibers, commonly inulin and fructooligosaccharides (FSO),
are fermented in the intestine, so as to stimulate growth of beneficial bacteria already in the gut.4
Recent research has examined the effects of probiotics and prebiotics
for alleviation of various health conditions. Overall, current research suggests a positive effect of probiotics and prebiotics in gastrointestinal transit
time, irritable bowel syndrome and ulcerative colitis.5–19 Much research has
shown a benefit of probiotics in antibiotic-associated diarrhoea.20–23 However,

Betz et al. in Nutrition & Dietetics 72 (2015)

3

a recent large randomized controlled trial showed no benefit of probiotic
supplementation in incidence of antibiotic-associated diarrhoea.24 Clarification is needed to determine what dose and which strains are beneficial for
different health conditions.
Although a substantial increase in consumption of probiotic- and prebiotic-containing products has been seen in the last decade, the current consumer knowledge, use and perceptions of these products has not been examined. Therefore, the purpose of the present research was to gain a better
understanding of how many, which types, and for what purpose hospital patients are taking probiotic and prebiotic products, and to compare differences based on patient demographics.
Methods
This was a descriptive, cross-sectional study designed to describe the knowledge, use and perceptions of probiotics and prebiotics of patients at two
large urban hospitals in Chicago. Inclusion criteria were adults aged 18 years
and over, admitted to the hospital within the previous 72 hours and those
who were oriented to person, place and time. Subjects were excluded from
the study if they could not speak or understand English, were located on
the pediatric, psychiatric, obstetrics/gynecology, oncology or intensive care
unit floors, had contact or airborne precautions, or did not give their consent. Ethical approval from the Institutional Review Boards at Rush University Medical Center and Christ Advocate Medical Center was obtained before
study initiation and conforms to the provisions of the Declaration of Helsinki.
The questionnaire used in this study was developed without modelling
from any previously developed tool. The tool was created to quantitatively
and qualitatively measure probiotic and prebiotic knowledge use and perceptions. Ten pilot interviews were performed with nutrition experts to evaluate the content, flow and ease of administering the questionnaire. An additional 10 pilot interviews were completed with patients; as no changes were
made to the questionnaire after these pilot interviews, the pilot interviews
were included in the final sample.
The questionnaire consisted of 18 questions; questions addressing
knowledge of probiotic and prebiotic terms and concepts were asked first.
Only patients familiar with the concept of probiotics or prebiotics answered
questions about perceptions. Additional questions included beliefs regarding probiotic and prebiotics benefit to health conditions, current or past
consumption, and reasons for consuming these products. Questions addressing influences on use and perceptions regarding safety were included.
All questions had corresponding handouts with examples of health conditions, probiotic and prebiotic products, and a rating scale (1 = not at all; 2
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= a little; 3 = somewhat; 4 = quite a bit; 5 = very much) as a guide for patient response. Probiotic and prebiotic products were chosen for handouts
based on products researchers believed to be most accessible to consumers and most commonly consumed. In addition, demographic information
was obtained.
Eligible patient units and patients within each unit were randomized
using a random numbers table. A maximum of seven questionnaires were
completed each data collection day. Enough patients were approached to
obtain 100 completed questionnaires at each hospital. After a patient was
randomly chosen, the patient was approached, a cognitive assessment was
completed, and the patient was provided a letter of introduction. Two study
coordinators performed all interviews and directly recorded answers into
Survey Monkey. After the interview was completed, patients were offered a
handout with information about probiotics and prebiotics as well as examples of products. Patients were not told about this information prior to the
interview to avoid response bias.
The Statistical Package for the Social Sciences (SPSS) Version 17.0 (SPSS,
Inc., Chicago, IL, USA) was used for data analysis. Descriptive statistics were
run for all items; means, standard errors and frequencies were calculated
to describe distributions and differences in knowledge and use of probiotics and prebiotics. Differences across gender, age, race and education level
were analyzed with chi-squared analysis. Data were normally distributed;
therefore, analysis of variance was used to assess differences across demographic characteristics and variables for which a mean could be calculated.
Results
Of the 300 patients that were asked to complete the survey, 100 declined
to participate. A total of 200 patients completed the study (67% response).
Women comprised 58% of the sample, the mean age of participants was 56
years, and a majority of patients were Caucasian (56%). Most patients (46%)
had completed 12 or less years of education, 43% had completed 13–16
years and 12% had completed 17 or more years.
When patients were asked if they were familiar with the term “probiotic”
or “prebiotic”, 43% and 11% of patients were familiar with the terms, respectively. From a selection of five definitions, 20% of patients who stated they
were familiar with the term chose the correct definition: “probiotics are live
bacteria that are helpful to your health when you eat them.” Incorrect definitions of the term “probiotic” offered to patients included natural antibiotics, fibers to help feed good bacteria, cleaning products to kill bacteria
and agents to make food taste sweeter. A total of 7% of patients chose the
correct definition of a prebiotic: “prebiotics are foods that you eat that help
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Table 1. Perceptions of probiotics and prebiotics grouped by medical center patient demographics.(a)
Mean ± SD(b,c)
Probiotics are
harmful
		
		
Overall

Probiotics are
safer than
prescription
drugs

Health claims
Prebiotics are
on probiotic
harmful
packages can		
be trusted		

Prebiotics are
safer than
prescription
drugs

Health claims
on prebiotic
packages can
be trusted

1.27 ±± 0.64

3.29 ± 1.35

2.95 ± 1.10

1.20 ± 0.52

3.29 ± 1.34

3.14 ± 1.08

Female

1.25 ± 0.62

3.40 ± 1.37

3.10 ± 1.18

1.24 ± 0.55

3.31 ± 1.34

3.21 ± 1.07

Male

1.30 ± 0.66

3.14 ± 1.32

2.75 ± 0.98

1.14 ± 0.47

3.26 ± 1.35

3.02 ± 1.08

45

1.15 ± 0.52x

3.76 ± 1.14x

3.11 ± 0.99x

1.12 ± 0.4x

3.55 ± 1.23x

3.21 ± 1.19

45–65

1.23 ± 0.60

3.13 ± 1.40y

3.15 ± 1.13x

1.09 ± 0.3x

3.43 ± 1.38x

3.30 ± 1.04

65

y

1.49 ± 0.76

y

2.97 ± 1.39

2.44 ± 1.05

y

1.47 ± 0.7

y

2.80 ± 1.27

2.79 ± 0.94

≤ 12

1.46 ± 0.78x

3.04 ± 1.43

2.88 ± 1.12

1.28 ± 0.62

3.30 ± 1.41

3.15 ± 1.17

13–16

1.12 ± 0.45y

3.61 ± 1.14

2.96 ± 1.11

1.17 ± 0.48

3.33 ± 1.19

3.06 ± 1.00

≥ 17

1.26 ± 0.62

2.96 ± 1.55

3.09 ± 1.08

1.07 ± 0.52

3.13 ± 1.60

3.33 ± 1.05

Gender

Age group (years)

y

Education (years)

(a) Based on total number of subjects who responded knowing probiotic (n = 146) or prebiotic concept (n = 103).
(b) Scale: 1 = not at all; 2 = a little; 3 = somewhat; 4 = quite a bit; 5 = very much.
(c) Different letters signify significant differences within demographic: P < 0.05 using analysis of variance.
SD, standard deviation.

feed the good bacteria in your body.” Incorrect definitions of the term “prebiotic” offered to patients included live bacteria helpful to health, a type of
vitamin, drugs to help lower blood pressure and harmful chemicals. After
these, correct definitions were briefly explained; 73% and 52% of the original 200 patients were familiar with the concepts of probiotics and prebiotics, respectively.
Patients with more years of education were more likely to be familiar with
the term “probiotic” (P < 0.000) than those with less education. Patients who
were younger than 45 years of age (P = 0.011), and who had more education (P = 0.001) were more likely to be familiar with the probiotic concept
compared with those older than 45 years of age, or with less education. No
significant differences in knowledge of the prebiotic term or concept were
found based on demographic characteristics.
Patient perceptions of probiotics and prebiotics are shown in Table 1.
Overall, patients did not believe that probiotics or prebiotics were harmful,
as evidenced by 90% of patients responding with “not at all” or “a little” to
the statement “probiotics are harmful.” The majority (95% of patients) chose
these responses for prebiotics. Patients aged less than 45 years believed probiotics and prebiotics to be safer than other age groups (P = 0.039).
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A majority of patients identified both probiotics and prebiotics as benefiting gastrointestinal health (Table 2), with the greatest benefit believed to
be for both constipation and diarrhea (greater than 87% and 78% believed
probiotics and prebiotics benefit these conditions, respectively). This is likely
because the majority of advertising for these products is targeted for gastrointestinal health. Use of probiotics and prebiotics for both immune and
heart health were also perceived as beneficial.

Table 2. Health conditions for which patients believe probiotics and prebiotics are beneficial and for which patients consume probiotics and prebiotics.
Believed
beneficial 		
Health condition
Probiotics

n

(a)

%

Consumed
(b)

n

(a)

%(c)

Constipation

56

89

14

25

Overall digestion/gut health

54

86

23

41

Diarrhoea

Immune health
Heart health

Overweight/obesity
Allergies

Mental health/stress
To taste/to try(d)

Prebiotics

55
43
38
42
35
27
–

87
68
60
67
56
43
–

5
6
0
3
0
0

19

9

11
0
5
0
0

34

Constipation

22

79

6

18

Overall digestion/gut health

21

75

7

21

Diarrhoea

Immune health
Heart health

Overweight/obesity
Allergies

Mental health/stress
To taste/to try

22
20
20
15
13
16
–

79
71
71
54
46
57
–

0
6
2

13
0
0

13

0

18
6

39
0
0

39

(a) Total number of subjects who indicated probiotics or prebiotics to be helpful for a specific condition or consumed for a condition.
(b) Based on total subjects who responded knowing probiotic (n = 63) or prebiotic (n = 28)
concept; percentage total is greater than 100 because subjects could choose more than
one answer.
(c) Based on total subjects who consumed probiotics (n = 56) or prebiotics (n = 33); percentage total is greater than 100 because subjects could choose more than one answer.
(d) To taste/to try was not included when asked for which health conditions probiotics and
prebiotics are beneficial.
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Consumption of probiotics and prebiotics for specific health conditions
was also assessed (Table 2). Similar to what was believed beneficial, patients
were most likely to consume probiotics for digestion and gut health, including constipation (25%). On the contrary, patients consumed prebiotics for
overweight/obesity and to taste or try.
Health conditions patients believed were most improved by probiotics
as indicated on the 5-point scale handout included immune health (3.70 ±
0.99) and digestion/gut health (3.08 ± 1.28). Overall, 34% of patients believed probiotics helped their health “quite a bit” or “very much.” Health conditions patients believed were most improved by prebiotics included general
health (4.00 ± 0.00), digestion/gut health (3.78 ± 1.26) and immune health
(3.31 ± 1.11). Overall, 33% believed prebiotics helped their health “quite a
bit” or “very much.” It was noted during data collection that many patients
stated they were consuming prebiotics for the benefits of fiber, and not
the prebiotic properties these products provide. Many patients mentioned
their belief that if they had consumed both probiotic and prebiotic products
more regularly, they would have seen more health benefits, although this
question was not asked formally as part of the survey and was only mentioned by patients during data collection. Therefore, many may have chosen a lower extent of improvement score as they were not taking the products on a regular basis.
Slightly more than half (53%) of patients were consuming or had consumed probiotics (Table 3). The most common probiotic was Activia. Female patients (P = 0.029) and those who had completed more education
(P < 0.000) were more likely to consume probiotics than men or those with
less education.
Fewer patients (38%) had consumed prebiotics (Table 3). The percentage of patients who were consuming prebiotics may have been higher if
more prebiotic products had been listed on the handout, as a wide variety
of products contain prebiotics. The most common prebiotic products consumed were Kashi Go Lean Crunch (Kashi Co.) (26% of all prebiotic products consumed), Skinny Cow (Weight Watchers International, Inc.) ice cream
sandwiches (26%) and Ensure (Abbott Nutrition) with FOS (20%). Patients
who had completed more years of education were more likely to consume
prebiotics (P < 0.000) than those with less education.
Television or radio most influenced probiotic consumption, with 57%
of patients being influenced by these forms of media. Interestingly, dietitians (10%) and the Internet (3%) did not have a large impact on probiotic
consumption. Similarly, patients were influenced to consume prebiotics by
television or radio (37%), although family or friends had the largest impact
(51%). Dietitians (21%) and the Internet (1%) appeared to have a lesser impact on prebiotic consumption.
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Table 3. Medical center patient probiotic and prebiotic product consumption.
Probiotics

n

%(a)

Consumption practice 			
Ever consumed probiotics
Currently consuming

(c)

105

83

		 Activia

		 YoPlus Yoplait yogurt
		 GoodBelly yogurt

		 Lowell Polish yogurt
Dairy drink

		 DanActive dairy drink
		 Kefir

		 Activia dairy drink

		 Other (unspecified)
Pill

		 Florajen

		 Florastor

		 Other (pills unspecified)
Cereals

		 Vive Kashi

42		

Daily

2–3 times per week
Weekly

Monthly

Infrequently/rarely

8 oz

>8 oz
1 pill

2 pills
3 pills

Currently consuming

Product

%(b)

76

38

62

31

72 		

Kashi Go Lean Crunch

32

26

16

10		

Ensure with FOS

20

16

1

1 		

93
4

31
16

12

59 		
3 		

20 		

10 		
8

1

1

11

7

1
1

1

2

1

2

7

5

5 		

126
14
6

6
4

1

Breakstones LiveActive cottage cheese

Frequency of consumption

8

54

Other

19
16
2
1

16
13
2
1

1

40 		

5

South Beach Diet bars

26

6

63
20

Luna bar

32

1

1
9

Skinny Cow ice cream sandwiches

1

13 		
3		

34 		

Serving size 			
4 oz

Ever consumed prebiotics(d)

n

113

Frequency of consumption 			
Once per day

Consumption practice

53 		

Product 			
Yogurt

Prebiotics

80

Once per day
Daily

Weekly

Monthly

Infrequently/rarely
As needed

Serving size

9 		

4 		
4 		
3 		

1		

1 each
2 each
4 each

1

30
33
7

1

25
27
6

49

40

62

51

2

9
1

2

7
1

≤1 cup

37

30

3+ cups

3

3

2 cups

10

8

(a) Percentage of total based on 157 responses.
(b) Percentage of total based on 122 responses.
(c) Significantly more females were consuming probiotics.
(d) Significant difference found based on education; highest education group had the highest percentage of
consumption of prebiotics.
FSO, fructooligosaccharides.
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Discussion
At the present time, there is a gap in the literature regarding probiotic and
prebiotic knowledge, use and perceptions in a hospitalized patient population as previous studies have used a free-living population. For example, a 2008 survey by the Research Opinion Corporation found that 85% of
people interviewed reported knowing “little to nothing” about probiotics;
a survey by Kraft foods found similar results revealing 63% of people interviewed were not at all familiar with probiotics.25 In the current study, 57%
of patients reported being unfamiliar with the term “probiotic” without any
further explanation of the term after the definition was explained; 73% of
patients interviewed were familiar with the concept of probiotics compared
with only 15% found by the Research Opinion Corporation.25 The higher familiarity found in this study may be due to the fact that the questionnaire
was completed 2 years after the previous study and the market and advertising for probiotics has increased dramatically in recent years.26 Kraft foods
found that only 13% of those familiar with probiotics could define them accurately compared with 40% in the current study. This discrepancy may be
due to differences in questionnaire design or population sampled (hospitalized vs free-living).
A 2007 consumer attitudes survey in a free-living population found 37%
of individuals were consuming probiotics for immune health and 41% for
digestive health compared with 11% for immunity and 41% for digestion
in the current study.27 The consumer attitudes survey found 37% of people
were consuming prebiotics for digestion compared with 18% for digestion
in the current study; however, 36% were consuming prebiotics for general
gut health. In 2009, yoghurt was the most popular mode of administration
of probiotics, consistent with the current study where most (66%) probiotic
products consumed were a type of yoghurt.28 In 2009, a business analysis
company (Datamonitor) reported that 14% of people interviewed thought
that probiotic health claims were untrustworthy compared with 40% of patients responding with either “not at all” or “a little” when asked if health
claims on probiotic packages can be trusted.26
There are several strengths to this study. This study covered a wide range
of questions to help understand probiotic and prebiotic knowledge use, and
perceptions. New and novel information was gathered, such as perceived
extent of improvement with probiotic and prebiotic intake by health condition, frequency and serving size of consumption, factors influencing consumption, and comparisons by demographic factors. It is valuable to assess
these parameters in hospitalized patients as this specific population may
differ from the general population because of the potential for their health
status to encourage use of dietary means of improving health. Of note, no
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probiotic or prebiotic products were offered in the hospital setting; therefore, dietary intake in the hospital likely did not influence responses.
Limitations to this study include a small sample size. Our sample was
taken from two urban medical centers and therefore, results cannot be generalized to free-living populations outside of this geographical environment.
This study likely does not offer a comprehensive description of probiotic and
prebiotic consumption because of the limited number of products on the
handouts used in the study. It is likely that this is especially true for prebiotics because of the large variety of products containing prebiotics. The type
of products (e.g. yoghurts, bars, dairy drinks) reported to be consumed may
have also been influenced by the type of products on the handout. While we
saw differences in probiotic and prebiotic knowledge and intake by education level, our ability to compare these groups is limited because of the differences in samples sizes between groups. In addition, information related
to past medical history information was not collected; the health status of
patients may have influenced whether patients consumed probiotics or prebiotics and for which health conditions they were consumed.
In conclusion, this study demonstrated that many patients at two large,
urban medical centers are consuming products containing probiotics and
prebiotics despite not understanding the true meaning of these terms. Probiotics are much better recognized by inpatients compared with prebiotics.
Inpatients are consuming probiotics mostly for gastrointestinal concerns and
prebiotics to help reduce overweight and obesity. In light of these findings,
it is important that healthcare professionals, including dietitians, are aware
of patient probiotic and prebiotic consumption. This consumption provides
cause for dietitians to inquire about use and to provide patient education to
ensure that both probiotics and prebiotics are being consumed safely and
for health conditions supported by research.
Funding — We have no financial or material support to report; no funding was used
for this research.
Conflict of interest — None of the authors or affiliated institutions associated with
this article has any financial or personal relationship or affiliation that could influence the present work.
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